377P Aumolertinib as second-line therapy in T790M-positive or-negative patients with EGFR-mutated non-small cell lung cancer (NSCLC): A retrospective study
- Resource Type
- Source
- Annals of Oncology. 33:S1589
- Subject
Oncology Hematology - Language
- ISSN
- 0923-7534